Connect with us

Technology

Improving Private Equity Due Diligence and Growth – Ed Marsh Announces Quality of Sales Event

Published

on

Ben Tagoe and Ed Marsh Will Share Tips on using Quality of Sales to Buy Smarter, Grow Faster and Exit Stronger – June 18th, 11:30et LinkedIn Live

BOSTON, June 5, 2024 /PRNewswire-PRWeb/ — High rates, lots of eager money chasing deals, and increasing prices are challenging private equity managers. The playbook of operational efficiency improvements is less effective. The other lever, revenue growth, is the least predictable. The margin for error is shrinking just as investment thesis realization now hinges on the most subjective of criteria—the sales team’s ability to execute.

Quality of Sales empowers financial buyers in several ways through informed buying decisions with accurate models, insights into root causes of portfolio underperformance, and tools to consistently hire superb sales talent.

“Quality of Sales” solves for this, as Ed Marsh and Ben Tagoe will explore in an important LinkedIn live event on June 18th at 11:30AM ET. (Registration required.)

Recent Bain research predicts that revenue growth and margin expansion will determine 65% of PE value creation for exits by 2025 – a 48% increase over the relative contribution of those two factors for exits in ’16-21.

But how often are sales teams delivering? Most sales teams struggle with implementing price increases and closing more deals with new logos. Traditional Quality of Earnings (QoE) due diligence only indirectly infers the sales team’s ability through pipeline review and renewal rates.

Ed Marsh, founder of Ed Marsh Consulting, says “Retrospective QoE due diligence is no longer adequate for investors’ high-stakes decisions that hinge on sales team execution. I’m really excited that Ben will bring his PE experience to this QoS briefing.”

Quality of Sales delivers highly accurate quantitative and qualitative insights into a sales team’s ability to execute key elements of an investment thesis including market share expansion, price increase implementation and opportunity creation. It also looks at specific factors that impact deal qualification and forecast accuracy

Research shows that 40% or more of sales reps are chronically missing quota in today’s market, and that 40% of forecast deals end in no decision. Those weaknesses carry large direct, and enormous opportunity cost implications for financial investors.

Ben Tagoe, CEO of PE-backed Objective Management Group continues, “Quality of Sales provides sponsors with diagnostics about a company’s pipeline health, insights into root causes of sales underperformance, and tools to consistently hire superb sales talent.”

The LinkedIn live info session will be held on June 18th, at 11:30AM ET (attendees must preregister here) and will cover the following aspects of Quality of Sales:

Sales Team Evaluation – deep dive insights into aggregate and individual strengths and opportunities. This includes sales leadership, management, and individual contributors in all sales roles. Investors will clearly understand the potential of the team to execute on the investment thesis, as well as required personnel and organizational changes and training requirements, including a reasonable timeline.Identify root causes of underperforming portfolio companies – as holding periods lapse, frustrating sales symptoms come into focus. But addresing symptoms doesn’t deliver results. Just as in operations the key is to understand root causes. Quality of Sales delivers that detail.Improved sales hiring – Hiring is a crap shoot. Even successful sales leaders from elsewhere in the portolio may not replicate success as markets, sellers, and buyers change quickly. The direct and opportunity costs of average hires is huge. Quality of Sales enables confidence in consistently hiring 2nd and 3rd standard deviation talent.

The Quality of Sales event will be broadcast live on LinkedIn on June 18th at 11:30AM ET. Register here to save your seat and gain critical insights into how you can quantitatively improve results.

Buy smarter. Grow faster. Exit strong.

A new private equity environment demands more accurate and insightful solutions to support your investments. Quality of Sales delivers empirical, predictively accurate insights.

About Ed Marsh: Ed is the founder of Ed Marsh Consulting, a firm that works with privately held middle-market firms on revenue growth. Ed’s a graduate of Johns Hopkins University and a former Ranger Qualified Airborne Infantry officer. He has extensive international experience and was the Export Advisor to American Express. He holds a Private Directors Association certificate in Private Equity Portfolio Company Governance and is Directorship® Certified by the National Association of Corporate Directors.

About Ben Tagoe: Benjamin Tagoe is the CEO of Objective Management Group, the pioneer and industry leader in sales team evaluations and sales candidate assessments. He’s a graduate of Princeton University and Harvard Business School where he was a Baker Scholar. Ben’s finance and investing career has focused on strategy and the use of data to drive better decisions. From Goldman Sachs and JP Morgan Chase, through his time as SVP at VantageScore Solutions, and Fairfield Enterprises (a single company fund), using data to drive better decision-making has been Ben’s passion – a passion that he brings to OMG and helping companies improve sales.

Media Contact

Ed Marsh, Ed Marsh Consulting, 9788100351, em@cgbadv.com, www.EdMarshConsulting.com 

View original content:https://www.prweb.com/releases/improving-private-equity-due-diligence-and-growth—ed-marsh-announces-quality-of-sales-event-302164421.html

SOURCE Ed Marsh Consulting

Continue Reading

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

on

By

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

on

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

on

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Trending